Roche is investigating one case of progressive multifocal leukoencephalopathy (PML) in a patient with multiple sclerosis (MS) after treatment with ocrelizumab (Ocrevus).
The Roche said that according to the treating physician, the case is a “carryover” from treatment with natalizumab (Tysabri, Biogen), which is known to be associated with PML. It reports that the patient, who was JC virus (JCV) positive, had been treated with natalizumab for 3 years, with the last infusion in February 2017.
Posted: 2017-08-09 Scientists, including those of Indian origin, have identified a molecule that can prevent breast cancer growth when traditional therapies stop working. First-in-class drugs work by
On 15 May 2017, the Ministry of Health and Family Welfare-Government of India (MoHFW) reported three laboratory-confirmed cases of Zika virus disease in Bapunagar area, Ahmedabad District, Gujarat, St
Nature Vs Chemicals March 20, 2017 |Dr. Matcha Sai Kumar Hi friends last two sessions we have seen what diabetes is and how to manage diabetes in diabetes patients. I hope all of you got some good inf